[1] BLOMBERY P, KIVIVALI L, PEPPERELL D, et al.Diagnosis and management of thrombotic thrombocytopenic purpura (TTP) in Australia: findings from the first 5 years of the Australian TTP/thrombotic microangiopathy registry[J].Intern Med J, 2016, 46(1): 71-79.
[2] JOLY B S, COPPO P, VEYRADIER A. Thrombotic thrombocytopenic purpura[J]. Blood, 2017, 129(21): 2836-2846.
[3] 鲁旭娟, 李笑峰, 陈满强, 等. 影响获得性血栓性血小板减少性紫癜首次缓解期内复发的相关指标研究[J]. 国际输血与血液学杂志, 2016, 39(5): 374-379.
[4] M A R I O T T E E , V E Y R A D I E R A . T h r o m b o t i c thrombocytopenic purpura: from diagnosis to therapy[J].Curr Opin Crit Care, 2015, 21(6): 593-601.
[5] MATSUMOTO M, FUJIMURA Y, WADA H, et al.Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) 2017 in Japan[J]. Int J Hematol, 2017, 106(1): 3-15.
[6] TANHEHCO Y C, AREPALLY G, METJIAN A. Novel therapeutic approaches for thrombotic thrombocytopenic purpura[J]. Curr Opin Hematol, 2017, 24(6): 521-528.
[7] JAIME-PéREZ J C, AGUILAR-CALDERóN P E,SALAZAR-CAVAZOS L, et al. Evans syndrome: clinical perspectives, biological insights and treatment modalities[J].J Blood Med, 2018, 9: 171-184.
[8] NORTON A, ROBERTS I. Management of Evans syndrome[J]. Br J Haematol, 2006, 132(2): 125-137.
[9] DHINGRA K K, JAIN D, MANDAL S, et al. Evans syndrome: a study of six cases with review of literature[J].Hematology, 2008, 13(6): 356-360.
[10] S A D L E R J E . P a t h o p h y s i o l o g y o f t h r o m b o t i c thrombocytopenic purpura[J]. Blood, 2017, 130(10): 1181-1188.
